Back to Search
Start Over
Supplemental Table 1 from Dual Inhibition of EGFR and c-Src by Cetuximab and Dasatinib Combined with FOLFOX Chemotherapy in Patients with Metastatic Colorectal Cancer
- Publication Year :
- 2023
- Publisher :
- American Association for Cancer Research (AACR), 2023.
-
Abstract
- Operating characteristics. A summary of the probability of stopping the trial early for the indicated true response rates.
Details
- Database :
- OpenAIRE
- Accession number :
- edsair.doi.dedup.....5e1507020a7c8559fc408126becd09af
- Full Text :
- https://doi.org/10.1158/1078-0432.22468061